Although Archer Aviation has struggled badly in recent sessions, its upcoming Q3 earnings report could be the opportunity to ...
Key features of Archer's business strategy could help the company eventually eclipse the valuation of rival Joby.
While Archer Aviation has been flying higher thanks to the potential of eVTOL aircraft, investors will also want some ...
TipRanks on MSN
Looking for Exposure to Archer Aviation Stock (ACHR) ahead of Q3 Earnings? Here’s How to Buy Without the Risk
Archer Aviation ($ACHR) is set to report its Q3 earnings on November 6. The electric vertical takeoff and landing (eVTOL) ...
Shares of Archer Aviation are trading lower Monday afternoon, seeing a pullback despite a series of positive announcements in ...
The EPA is proposing to delay HFC phaseout deadlines to ease refrigerant shortages and supply chain challenges.
In a recent interview on Bloomberg Businessweek Daily, Adam Goldstein, Chairman and CEO of Archer Aviation ($ACHR), shared ...
RectorSeal closes its acquisition of MARS Parts, adding motors, capacitors, relays, and contactors to its HVAC lineup.
Early data from the ADAPT JR trial suggest efgartigimod may benefit adolescents with generalized myasthenia gravis, a rare ...
Joby Aviation's third-quarter results are on deck, with rising costs and valuation concerns clouding investor sentiment.
Medpage Today on MSN
Myasthenia Gravis Drug Shows Benefits in Wider Range of Patients
Beyond the 4-week mark, both MG-ADL and Quantitative Myasthenia Gravis scores improved in the overall population and in all ...
MedPage Today on MSN
Myasthenia Gravis Complement Inhibitor Meets Primary Endpoint in Phase III Trial
Investigational gefurulimab met its primary efficacy endpoint in adults with anti-acetylcholine receptor (AChR) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback